-
Patient Optimism and the Trade-Off Between Kidney Quality and Waiting Time
Mar 10, 2025, 14:00 PM -
Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/ Refractory Neuroblastoma – Matching-Adjusted Indirect Treatment Comparison and Economic Evaluation in the Private Health Insurance System in Brazil
Mar 10, 2025, 14:00 PM -
Budget Analysis of the Implementation of Biosimilars in a Large Private Health Insurance Company in Southern Brazil
Mar 10, 2025, 14:00 PM -
Content Validation of the NEI-VFQ-25 With Patients With Subfoveal and Non-subfoveal Geographic Atrophy: A Qualitative Study
Mar 10, 2025, 14:00 PM -
Symptom Burden of Acute Influenza Infection Among US Adults: An Interim Analysis of a Nationwide Prospective Study
Mar 10, 2025, 14:00 PM -
Renal Cell Carcinoma and Muscle Invasive Bladder Cancer Patients' Perception of Risk and Fear of Recurrence
Mar 10, 2025, 14:00 PM -
Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Intensity-Modulated Proton Therapy (IMPT) for the Treatment of Head and Neck Oropharyngeal Carcinoma
Mar 10, 2025, 14:00 PM -
Variability in Definitions and Measurement Approaches of Vaso-Occlusive Crises (VOCs) in Sickle Cell Disease (SCD): A Targeted Literature Review of Global Real-World Evidence (RWE) Studies
Mar 10, 2025, 14:00 PM -
PICC Line (PICC) or Central Inserted Venous Catheter (CICC ) in Cancer Patients: Comparative Effectiveness and Cost-Effectiveness Analysis in Brasil/LATAM/LMIC
Mar 10, 2025, 14:00 PM -
The Time Value of Money driven by Early Disease-Modifying Interventions in Degenerative Disease
Mar 10, 2025, 14:00 PM -
All for One and One for All? Patterns of Familial Influenza Vaccination
Mar 10, 2025, 14:00 PM -
Impact of NICE Severity Modifiers on Willingness-to-Pay Thresholds
Mar 10, 2025, 14:00 PM -
Developing and Evaluating Definitions of Real-World (rw) Clinical Endpoints for Patients with Early-Stage Triple Negative Breast Cancer (esTNBC) Using a US Secondary Database
Mar 10, 2025, 14:00 PM -
Understanding Racial Differences in Emergency Room Visits for Patients with Lupus
Mar 10, 2025, 14:00 PM -
Dupilumab Improves Health-Related Quality Of Life And Asthma Control In Patients With And Without Coexisting Type 2 Conditions: Results From The RAPID Study
Mar 10, 2025, 14:00 PM -
Population-Level Impact of Emicizumab for Hemophilia A Patients in Six Latin American (LATAM) Countries: A 25-Year Model
Mar 10, 2025, 14:00 PM -
Evaluation of Availability, Prices, and Affordability of Medicines for Hepatitis B and Hepatitis C Viruses at Community Pharmacies in a Senatorial District in North-Central Nigeria
Mar 10, 2025, 14:00 PM -
Eosinophilic Esophagitis-Related Healthcare Resource Utilization: A Retrospective Cohort Study of US Health Insurance Claims Data
Mar 10, 2025, 14:00 PM -
Improving Cancer Recurrence Detection using ctDNA Measures in Colorectal, Breast, and Non-small Cell Lung Cancers
Mar 10, 2025, 14:00 PM
